Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Neoadjuvant Pembrolizumab, Carboplatin and Paclitaxel in Triple-negative Breast Cancer

Tel Aviv Medical Center · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
breastcancerimmunotherapypembrolizumabtripletriplenegativebreastcancer
triple negative breast cancer, immunotherapy, pembrolizumab, breast cancer, triple-negative breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 917821
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.